Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,930 JPY | -1.01% | +1.10% | +24.21% |
02-21 | Japanese Shares Slump for Second Day After Business Sentiment Data | MT |
02-21 | Espec's Nine-Month Attributable Profit Nearly Doubles as Orders Reach All-Time High | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company is highly valued given the cash flows generated by its activity.
Ratings chart - Surperformance
Sector: Industrial Machinery & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+24.21% | 416M | - | ||
+12.96% | 82.32B | A- | ||
+16.38% | 68.15B | B | ||
+12.13% | 37.47B | B- | ||
+19.98% | 32.88B | A | ||
+12.78% | 28.75B | B- | ||
+3.33% | 26.79B | C+ | ||
+0.73% | 25.18B | B+ | ||
+13.59% | 24.83B | B+ | ||
+16.37% | 24.4B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 6859 Stock
- Ratings Espec Corp.